Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors.

Gallois C, Ambrosini M, Lonardi S, Alouani E, Guimbaud R, Overman MJ, Sinicrope F, Mazard T, Decraecker M, Ros J, Elez E, Pernot S, Cremolini C, Boilève A, Parent P, Jayachandran P, Dutherage M, Mercier M, Flecchia C, Fakih M, Sclafani F, Pietrantonio F, Taieb J, Tougeron D